External Nasal Dilator Market Research, 2033
The global external nasal dilator market was valued at $98.3 million in 2023, and is projected to reach $162.4 million by 2033, growing at a CAGR of 5.1% from 2024 to 2033. Increase in the prevalence of respiratory disorders, snoring, sleep apnea, and innovations in materials and design are the driving factors of the market.
Market Introduction and Definition
External nasal dilators are innovative devices that are designed to enhance the nasal airflow by gently opening the nasal passages from the outside. These devices are especially beneficial for people who have sleep apnea, nasal congestion, snoring, or who want to breathe better when exercising. External nasal dilators are designed to alleviate airflow constraints to improve breathing and general health.
Breathing becomes easier and nasal congestion can be relieved, especially for those who have nasal obstruction from allergies, colds, or structural problems. Many people snore because of airway blockage while they sleep, which is frequently brought on by narrower nasal passages. External nasal dilators facilitate improved airflow through the nose, which helps lessen snoring.
Key Takeaways
- The external nasal dilators market study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major external nasal dilator industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The global external nasal dilator market growth is due to several factors such as surge in the prevalence of sleep apnea, increasing popularity and adoption of external nasal dilators for, nasal congestion, snoring, or who want to breathe better when exercising. In addition, allergies, colds, sinusitis, and anatomical anomalies are major causes of nasal congestion. Thus, by enlarging the nasal passageways, external nasal dilators provide a non-invasive way to relieve nasal congestion and facilitate better airflow and breathing. Furthermore, snoring is also one of the factors that drives the market growth. Restrictions in airflow through the nasal passages are frequently linked to snoring, which causes vibrations in the soft tissues of the throat.
By widening the nasal airways, lowering airway resistance, and encouraging smoother airflow in sleep, external nasal dilators help reduction in snoring. Moreover, for treating nasal congestion and snoring, external nasal dilators provide a non-invasive option to surgery or prescription drugs. They are a good option for people looking for non-pharmacological ways to treat respiratory problems because they are simple to use, portable, and generally well-tolerated, thus are expected to boost the external nasal dilator market forecast.
Soft materials, customisable features, and understated designs characterize many external nasal dilators that are made with comfort and ease in mind. Users can easily integrate them into their everyday routines because they are simple to apply, remove, and clean. Thus, the aforementioned factors are anticipated to drive the market. However, cost and accessibility of these dilators may hinder the market growth. However, technological advancements, increasing prevalence of sleep apnea, snoring is expected to drive the external nasal dilator market opportunity.
Patent Analysis of Global External Nasal Dilator Market, 2015-2024
Although the growth of the external nasal dilator market share has been more rapid in recent years, the industry can draw on the patents filed by various companies. For instance, CNS Inc. and GlaxoSmithKline LLC dominated the same with 18.1% share each, further Corbett Lair Inc., holds a share of about 12.5%.
Market Segmentation
The external nasal dilator market analysis is segmented into application, end-user, distribution channel, and region. On the basis of application, the market is divided into snoring, sleep apnea, nasal congestion, and others. As per end-user, the market is segregated into adults and pediatric. On the basis of distribution channel, the market is bifurcated into online channel and offline channel. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America dominated the external nasal dilator market size owing to high prevalence of and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidences of sleep disorders such as sleep apnea, surge in demand fornasal dilators, the availability of advanced healthcare facilities with trained medical professionals, rise in number of R&D activities along with a large presence of key players, and surge in investment made by governments in the healthcare system.
However, Asia-Pacific external nasal dilator market size is expected to experience the highest growth rate during the forecast period. Moreover, India and China are expected to grow at high CAGR in the Asia-Pacific external dilator market majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced instruments, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of external nasal dilator.
Industry Trends
- Customizable external nasal dilators that accommodate unique nasal anatomy and preferences are becoming more and more popular. To guarantee a better fit and maximum performance for customers, some companies provide alternatives for individualized designs, adjustable tension, and size variations.
- To monitor breathing patterns, sleep quality, and other metrics, certain external nasal dilators are incorporating sensors or networking elements in line with the growing trend of wearable health technology. Thus, end users can learn more about their overall respiratory health and nasal airflow from this data.
- External nasal dilators have been promoted as ways to improve sleep quality by reducing snoring and treating symptoms of sleep-disordered breathing problems like sleep apnea, as sleep quality continues to garner attention as a critical component of overall well-being.
Competitive Landscape
The major players operating in the external nasal dilator industry include GlaxoSmithKline Plc, HealthRight Products LLC, Zhongshan Hongze Medical Technology Co., Ltd. Other players in external nasal dilator market includes Permira I.P Limited, Health Right Products LLC, AirWare Labs., ?Splintek Inc, Scandinavian Formulas, Tomed GmbH, Creganna, Nasilator, Hubei YJT Technology Co., Ltd, Rhinomed Limited, Nasilator, Nasanita, and Walgreen Co., ?and others and so on.
Recent Key Strategies and Developments
- The global medical device manufacturer Rhinomed improves nasal medication administration, sleep quality, upper respiratory disease diagnostics, and respiration. By increasing airflow through the nose by 38% on average, MuteTM can lessen the frequency and intensity of snoring and improve both of your morning feelings of refreshment. According to user trials, snorers can sleep easily knowing that they're enhancing both the quality of their partner's sleep and their own breathing.
Key Sources Referred
- National Center for Biotechnology Information
- National Council on Aging, Inc.
- World Health Organization (WHO)
- National Library of Medicine
- Australasian Sleep Association
- The United States Food and Drug Administration
- Houston Sleep Solutions
- Brazilian Sleep Association
- British Snoring & Sleep Apnoea Association
- U.S. Department of Health & Human Services
- American Academy of Allergy, Asthma & Immunology
- Asthma and Allergy Foundation of America
- Centers for Disease Control and Prevention
- Australian Institute of Health and Welfare
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, external nasal dilator market share for segments, current trends, estimations, and dynamics of the external nasal dilator market analysis from 2024 to 2033 to identify the prevailing external nasal dilator market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the external nasal dilator market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global external nasal dilator market trends, key players, market segments, application areas, and market growth strategies.
External Nasal Dilator Market Report Highlights
Aspects | Details |
Market Size By 2033 | USD 162.4 Million |
Growth Rate | CAGR of 5.1% |
Forecast period | 2024 - 2033 |
Report Pages | 280 |
By Application |
|
By End User |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | AirWare Labs, Splintek Inc, Rhinomed Limited, Tomed GmbH, Scandinavian Formulas, Zhongshan Hongze Medical Technology Co., Ltd., HealthRight Products LLC, Permira I.P Limited, Health Right Products LLC, GlaxoSmithKline Plc |
Snorers, sleep apnea and nasal congestion affected population are the upcoming trends of External Nasal Dilator Market in the globe.
Snoring is the leading application of the external nasal dilator market.
North America is the largest regional market for External Nasal Dilator.
The global external nasal dilator market was valued at $98.3 million in 2023, and is projected to reach $162.4 million by 2033, growing at a CAGR of 5.1% from 2024 to 2033.
The major players operating in the external nasal dilator market include GlaxoSmithKline Plc, HealthRight Products LLC, Zhongshan Hongze Medical Technology Co., Ltd. Other players in external nasal dilator market includes Permira I.P Limited, Health Right Products LLC, AirWare Labs., Splintek Inc, Scandinavian Formulas, Tomed GmbH, Creganna, Nasilator, Hubei YJT Technology Co., Ltd, Rhinomed Limited, Nasilator, Nasanita, SHREYAAS HEALTH CARE PVT LTD., and Walgreen Co. and others.and so on.
Loading Table Of Content...